Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease

Nuclear accumulation of AMPK-α1 induces brain atrophy, neuronal loss, and formation of Htt aggregates in a Huntington’s disease model.

• Publication year

  2011

• Venue

  Journal of Cell Biology

• Publication date

  2011-07-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1083/jcb.201105010PMID 21768291PMCID 3144412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• To eat or not to eat: the effect of AICAR on food intake regulation in yellow-bellied marmots (Marmota flaviventris)

  2010cited by this paper
• The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease.

  2010cited by this paper
• Longitudinal Evaluation of an N-Ethyl-N-Nitrosourea-Created Murine Model with Normal Pressure Hydrocephalus

  2009cited by this paper
• Immunological synapse formation inhibits, via NF-κB and FOXO1, the apoptosis of dendritic cells

  2009cited by this paper
• Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9.

  2009cited by this paper
• Impaired PGC-1alpha function in muscle in Huntington's disease.

  2009cited by this paper
• Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington’s disease

  2009cited by this paper
• Impaired PGC-1 a function in muscle in Huntington’s disease

  2009cited by this paper
• CCR7-Dependent Stimulation of Survival in Dendritic Cells Involves Inhibition of GSK3β1

  2009cited by this paper
• Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription

  2009cited by this paper
• Ca2+/Calmodulin-dependent Protein Kinases

  2008cited by this paper
• A novel approach of prophylaxis to HBV recurrence after liver transplantation.

  2008cited by this paper
• Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes

  2008cited by this paper
• Activation of AMP-activated Protein Kinase Induces p53-dependent Apoptotic Cell Death in Response to Energetic Stress*

  2008cited by this paper
• AICAR Induces Astroglial Differentiation of Neural Stem Cells via Activating the JAK/STAT3 Pathway Independently of AMP-activated Protein Kinase*

  2008cited by this paper
• Evidence for the involvement of CaMKII and AMPK in Ca2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle.

  2008cited by this paper
• Hypothalamic CaMKK2 contributes to the regulation of energy balance.

  2008cited by this paper
• AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3β and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver*

  2008cited by this paper
• Excitotoxic neuronal death and the pathogenesis of Huntington's disease.

  2008cited by this paper
• The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor*

  2007cited by this paper
• Dysregulation of C/EBPα by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease

  2007cited by this paper
• Disturbed Cross Talk between Insulin-Like Growth Factor I and AMP-Activated Protein Kinase as a Possible Cause of Vascular Dysfunction in the Amyloid Precursor Protein/Presenilin 2 Mouse Model of Alzheimer's Disease

  2007cited by this paper
• Metformin therapy in a transgenic mouse model of Huntington's disease.

  2007cited by this paper
• 膵癌細胞におけるAMP-activated protein kinase(AMPK)の役割

  2007influential reference
• Huntington's disease

  2007cited by this paper
• Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.

  2007cited by this paper
• 5′AMP-activated protein kinase α deficiency enhances stress-induced apoptosis in BHK and PC12 cells

  2007cited by this paper
• Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK-->ERK1/2 pathway.

  2007cited by this paper
• Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease.

  2007cited by this paper
• AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α

  2007cited by this paper
• Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation.

  2007cited by this paper
• AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha.

  2007cited by this paper
• Transcriptional Repression of PGC-1a by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

  2006cited by this paper
• Regulation of AMP-activated Protein Kinase by Multisite Phosphorylation in Response to Agents That Elevate Cellular cAMP*>

  2006cited by this paper
• AMP-activated protein kinase signaling in metabolic regulation.

  2006cited by this paper
• Regulation of the Nucleocytoplasmic Distribution of Snf1-Gal83 Protein Kinase

  2006cited by this paper
• 5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes

  2005cited by this paper
• Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity.

  2005cited by this paper
• Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.

  2005cited by this paper
• CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model

  2005cited by this paper
• Pharmacological Inhibition of AMP-activated Protein Kinase Provides Neuroprotection in Stroke*

  2005cited by this paper
• cAMP-response Element-binding Protein Contributes to Suppression of the A2A Adenosine Receptor Promoter by Mutant Huntingtin with Expanded Polyglutamine Residues*

  2005cited by this paper
• Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin.

  2004cited by this paper
• 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells.

  2004cited by this paper
• Huntingtin and the molecular pathogenesis of Huntington's disease

  2004cited by this paper
• 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells.

  2003cited by this paper
• 5′-AMP-activated Protein Kinase Controls Insulin-containing Secretory Vesicle Dynamics*

  2003cited by this paper
• AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase.

  2003cited by this paper
• Sequential activation of individual caspases, and of alterations in Bcl‐2 proapoptotic signals in a mouse model of Huntington's disease

  2003cited by this paper
• Sustained activation of AMP‐activated protein kinase induces c‐Jun N‐terminal kinase activation and apoptosis in liver cells

  2002cited by this paper
• Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization.

  2001cited by this paper
• AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise.

  2001cited by this paper
• Regulation of Transcription by AMP-activated Protein Kinase

  2001cited by this paper
• The regulation of AMP-activated protein kinase by phosphorylation.

  2000cited by this paper
• Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle.

  2000cited by this paper
• Higher sedentary energy expenditure in patients with Huntington's disease

  2000cited by this paper
• Cellular Distribution and Developmental Expression of AMP‐Activated Protein Kinase Isoforms in Mouse Central Nervous System

  1999cited by this paper
• Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.

  1999cited by this paper
• Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.

  1999cited by this paper
• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• Generation and characterization of embryonic striatal conditionally immortalized ST14A cells

  1998cited by this paper
• AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform.

  1998cited by this paper
• Expression of type VI adenylyl cyclase in the central nervous system: implication for a potential regulator of multiple signals in different neurotransmitter systems

  1998cited by this paper
• Ca 2+ /calmodulin-dependent protein kinase

  1997cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• The α1 and α2 isoforms of the AMP‐activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro

  1996cited by this paper
• Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism

  1996cited by this paper
• Isoform-specific Purification and Substrate Specificity of the 5′-AMP-activated Protein Kinase*

  1996cited by this paper
• Mammalian AMP-activated Protein Kinase Subfamily (*)

  1996cited by this paper
• The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro.

  1996cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Specificity determinants for the AMP‐activated protein kinase and its plant homologue analysed using synthetic peptides

  1993cited by this paper
• A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

  1991cited by this paper
• Huntington's disease. Pathogenesis and management.

  1986cited by this paper
• Huntington's disease

  1984cited by this paper
• Croup: pathogenesis and management.

  1983cited by this paper

• Endothelial KSR2 regulated by genetic variation protects against atherosclerosis through AMPKα1 stabilization

  2026cites this paper
• Neuroprotective Effects of Glucosamine in Huntington’s Disease Through NLRP3 Inflammasome Inhibition

  2025cites this paper
• Nuclear functional role of metabolic enzymes and related metabolites: Focus on gene expression regulation

  2025cites this paper
• Navigating the neuronal recycling bin: Another look at huntingtin in coordinating autophagy

  2025cites this paper
• Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington’s Disease

  2025cites this paper
• Correlation of autophagy and Alzheimer's disease with special emphasis on the role of phosphodiesterase-4

  2025cites this paper
• Dysfunctional BCAA degradation triggers neuronal damage through disrupted AMPK-mitochondrial axis due to enhanced PP2Ac interaction

  2025cites this paper
• The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3β inhibition

  2025cites this paper
• AMPK activation eliminates senescent cells in diabetic wound by inducing NCOA4 mediated ferritinophagy

  2024cites this paper
• Complex immunotoxic effects of T-2 Toxin on the murine spleen and thymus: Oxidative damage, inflammasomes, apoptosis, and immunosuppression.

  2024cites this paper
• Protective Effects of Antcin H Isolated from Antrodia cinnamomea Against Neuroinflammation in Huntington’s Disease via NLRP3 Inflammasome Inhibition

  2024influential citation
• Tetrabromobisphenol A induced p38-MAPK/AMPKα activation downstream-triggered CHOP signal contributing to neuronal apoptosis and death.

  2024cites this paper
• Targeted downregulation of insulin signaling restricts human tau pathogenesis by reinstating the aberrant heterochromatin loss and mTOR/4EBP/S6K pathway in Drosophila.

  2024cites this paper
• Nuclear PD-L1 compartmentalization suppresses tumorigenesis and overcomes immunocheckpoint therapy resistance in mice via histone macroH2A1

  2024cites this paper
• Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model.

  2024cites this paper
• An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington’s disease

  2024cites this paper
• NAD + precursor nutritional supplements sensitize the brain to future ischemic events

  2023cites this paper
• Mechanistic Insights and Potential Therapeutic Approaches in PolyQ Diseases via Autophagy

  2023cites this paper
• Fluorescent biosensors illuminate the spatial regulation of cell signaling across scales

  2023cites this paper
• From Kinases to Diseases: Investigating the Role of AMPK in Human Pathologies

  2023cites this paper
• Targeted Inhibition of Hsp90 in Combination with Metformin Modulates Programmed Cell Death Pathways in A549 Lung Cancer Cells

  2023cites this paper
• Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease.

  2023cites this paper
• A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington’s disease

  2022cites this paper
• A molecular and in vivo investigation of advanced prostate cancer: Deconstructing AMPK activity and developing an improved mouse model

  2022cites this paper
• Novel role of AMPK in cocaine reinforcement via regulating CRTC1

  2022cites this paper
• SREBP and central nervous system disorders: genetic overlaps revealed by in silico analysis.

  2022cites this paper
• Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington’s Disease

  2022cites this paper
• Metformin to treat Huntington disease: a pleiotropic drug against a multi-system disorder.

  2022cites this paper
• Defects of Nutrient Signaling and Autophagy in Neurodegeneration

  2022cites this paper
• Butyric Acid Precursor Tributyrin Modulates Hippocampal Synaptic Plasticity and Prevents Spatial Memory Deficits: Role of PPARγ and AMPK

  2022cites this paper
• Treadmill training attenuate STZ-induced congnitive dysfunction in Type 2 Diatetic Rats via modulating Grb10/ IGF-R signaling.

  2022cites this paper
• Development and maintenance of vision's first synapse.

  2021cites this paper
• Post-translational modifications: Regulators of neurodegenerative proteinopathies.

  2021cites this paper
• A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis

  2021influential citation
• AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration

  2021cites this paper
• Role of AMPK mediated pathways in autophagy and aging.

  2021cites this paper
• Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway

  2021cites this paper
• AMPK Localization: A Key to Differential Energy Regulation

  2021cites this paper
• Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases

  2021cites this paper
• A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS.

  2021cites this paper
• Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19

  2021cites this paper
• AMPK in the brain: its roles in glucose and neural metabolism

  2021cites this paper
• Contribution of Energy Dysfunction to Impaired Protein Translation in Neurodegenerative Diseases

  2021cites this paper
• Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling

  2021cites this paper
• Purine Nucleotides Metabolism and Signaling in Huntington’s Disease: Search for a Target for Novel Therapies

  2021cites this paper
• Highlighting the protective or degenerative role of AMPK activators in dementia experimental models.

  2021cites this paper
• Arsenic induces autophagy-dependent apoptosis via Akt inactivation and AMPK activation signaling pathways leading to neuronal cell death.

  2021cites this paper
• Metabolic Aspects of Adenosine Functions in the Brain

  2021cites this paper
• Neuroprotective effects of resveratrol against oxygen glucose deprivation induced mitochondrial dysfunction by activation of AMPK in SH-SY5Y cells with 3D gelatin scaffold.

  2020cites this paper
• Cr(VI) induces ROS-mediated mitochondrial-dependent apoptosis in neuronal cells via the activation of Akt/ERK/AMPK signaling pathway.

  2020cites this paper
• AMPK Modulates Associative Learning via Neuronal Mitochondrial Fusion in C. elegans

  2020cites this paper
• Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system

  2020cites this paper
• A transition to degeneration triggered by oxidative stress in degenerative disorders

  2020cites this paper
• Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer's Disease and Depression.

  2020cites this paper
• Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons.

  2020cites this paper
• This is a repository copy of Skeletal Muscle Modulates Huntington's Disease Pathogenesis in Mice: Role of Physical Exercise. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/150506/

  2020cites this paper
• Isoform-specific roles of AMPK catalytic α subunits in Alzheimer's disease.

  2020cites this paper
• A Novel Zinc Chelator, 1H10, Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Zinc Toxicity and AMPK Activation

  2020cites this paper
• New Synthetic 3-Benzoyl-5-Hydroxy-2H-Chromen-2-One (LM-031) Inhibits Polyglutamine Aggregation and Promotes Neurite Outgrowth through Enhancement of CREB, NRF2, and Reduction of AMPKα in SCA17 Cell Models

  2020cites this paper
• Adenosine signaling and its downstream target mod(mdg4) modify the pathogenic effects of polyglutamine in a Drosophila model of Huntington’s disease

  2020cites this paper
• Spatial control of AMPK signaling at subcellular compartments

  2020cites this paper
• Protective effects of fusidic acid against sodium nitroprusside-induced apoptosis in C6 glial cells.

  2019cites this paper
• Metabolic aspects of neuronal degeneration: From a NAD+ point of view.

  2019cites this paper
• Physical Activity Alleviates Cognitive Dysfunction of Alzheimer’s Disease through Regulating the mTOR Signaling Pathway

  2019cites this paper
• Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease

  2019cites this paper
• Heat Shock Factor 1 Is a Direct Antagonist of AMP-Activated Protein Kinase.

  2019cites this paper
• PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1)

  2019cites this paper
• Could metformin be therapeutically useful in Huntington’s disease?

  2019cites this paper
• Fluid flow-induced activation of subcellular AMPK and its interaction with FAK and Src.

  2019cites this paper
• The D2 Dopamine Receptor Interferes With the Protective Effect of the A2A Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration

  2018cites this paper
• PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.

  2018cites this paper
• Metabolic regulation of female puberty via hypothalamic AMPK–kisspeptin signaling

  2018cites this paper
• Metabolic studies of a patient harbouring a novel S487L mutation in the catalytic subunit of AMPK.

  2018cites this paper
• A genetic modifier suggests that endurance exercise exacerbates Huntington's disease

  2018cites this paper
• GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons

  2018cites this paper
• Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes

  2018cites this paper
• Reduced sirtuin 1/adenosine monophosphate‐activated protein kinase in amyotrophic lateral sclerosis patient‐derived mesenchymal stem cells can be restored by resveratrol

  2018cites this paper
• The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease

  2018cites this paper
• Mitochondrial Dysfunction in Huntington's Disease.

  2018cites this paper
• mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival.

  2018cites this paper
• Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise

  2018cites this paper
• AMP-Activated Protein Kinase Is Essential for the Maintenance of Energy Levels during Synaptic Activation

  2018cites this paper
• AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration.

  2017cites this paper
• Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington’s Disease

  2017cites this paper
• Dissecting the role of AMP-activated protein kinase in human diseases

  2017cites this paper
• Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons

  2017cites this paper
• Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots

  2017cites this paper
• Mechanisms underlying neurodegeneration in Huntington disease: applications to novel disease-modifying therapies.

  2017cites this paper
• α-Synuclein binds and sequesters PIKE-L into Lewy bodies, triggering dopaminergic cell death via AMPK hyperactivation

  2017cites this paper
• Metformin intake associates with better cognitive function in patients with Huntington's disease

  2017cites this paper
• Surface wetting strategy prevents acute heat exposure-induced alterations of hypothalamic stress- and metabolic-related genes in broiler chickens.

  2017cites this paper
• AMPK signaling in the nucleus accumbens core mediates cue-induced reinstatement of cocaine seeking

  2017cites this paper
• Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis

  2017cites this paper
• Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons.

  2017cites this paper
• Huntington’s Disease and Mitochondria

  2017cites this paper
• Metformin promotes neuronal differentiation and neurite outgrowth through AMPK activation in human bone marrow–mesenchymal stem cells

  2017cites this paper
• Towards an Understanding of Energy Impairment in Huntington’s Disease Brain

  2017cites this paper
• Targeting ENT1 and adenosine tone for the treatment of Huntington's disease

  2017cites this paper
• Analysis of mitochondrial organization and function in the Drosophila blastoderm embryo

  2017cites this paper
• Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics

  2016cites this paper